Holding(s) in Company
October 10 2003 - 6:17AM
UK Regulatory
RNS Number:7627Q
Cambridge Antibody Tech Group PLC
10 October 2003
SCHEDULE 10
NOTIFICATION OF MAJOR INTERESTS IN SHARES
1) Name of company
Cambridge Antibody Technology
2) Name of shareholder having a major interest
Genzyme Corporation
3) Please state whether notification indicates that it is in respect of
holding of the shareholder named in 2 above or in respect of a
non-beneficial interest or in the case of an individual holder if it is a
holding of that person's spouse or children under the age of 18
As in 2) above
4) Name of the registered holder(s) and, if more than one holder, the
number of shares held by each of them
As in 2) above
5) Number of shares/amount of stock acquired
1,800,000 ordinary shares of 10 pence
6) Percentage of issued class
4.93%
7) Number of shares/amount of stock disposed
Nil
8) Percentage of issued class
N/A
9) Class of security
Ordinary 10 pence shares
10) Date of transaction
Shares issued and admitted to trading 25 September 2003
11) Date company informed
9 October 2003
12) Total holding following this notification
2,107,982
13) Total percentage holding of issued class following this notification
5.5%
14) Any additional information
15) Name of contact and telephone number for queries
Justin Hoskins, 01223 474471
16) Name and signature of authorised company official responsible for
making this notification
Diane Mellett, Company Secretary
Date of notification 10 October 2003
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLEAEEEFFKDFFE